Format

Send to

Choose Destination
See comment in PubMed Commons below
Histol Histopathol. 2005 Jul;20(3):969-75.

New aspects on the role of lipoxygenases in cancer progression.

Author information

  • 1Department of Molecular Pathology and Innovative Therapies, Polytechnic University of Marche, Via Ranieri, 60131 Ancona, Italy. catgfp@yahoo.it

Abstract

The Lipoxygenases (LOXs) are a class of enzymes that convert arachidonic, linoleic, and other polyunsaturated fatty acid into biologically active metabolites involved in the inflammatory and immune responses. Recent evidences indicate that LOXs and the signaling pathways that are involved in their activation are also important for carcinogenesis and tumor progression. LOXs should therefore receive as much attention from cancer researchers as it has already from immunologists. In this article, we will review some evidence that the LOXs pathways affect several aspects of lung, pancreatic and prostate cancer progression. Moreover, we discuss how this new perspective on the roles of LOXs and their metabolites can have important implications to cancer therapy.

PMID:
15944947
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for F. Hernandez
    Loading ...
    Write to the Help Desk